Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)

NCT04427280 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT04427280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04427280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
May 26, 2020
Completion date
June 29, 2021
Enrollment
153 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, coronavirus infection, infectious disease